JAMIE MUELLER: Open Payments
NPI 1689442998 · NEWFANE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 40 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $394 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 15 | $233 |
| SCPHARMACEUTICALS INC. | 2 | $139 |
| Merck Sharp & Dohme LLC | 3 | $63 |
| ABIOMED | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Amgen Inc. | 2 | $49 |
| Kestra Medical Technology Services, Inc. | 1 | $48 |
| ABBVIE INC. | 1 | $33 |
| Corcept Therapeutics | 2 | $32 |
Products named: ONPATTRO, FUROSCIX, VERQUVO, JARDIANCE, Assure WCD, QULIPTA, Korlym, REPATHA.
Industry payments across NY — which companies pay providers there.
